Acquiring Company
Piramal Pharma Limited
Acquired Company
Yapan Bio Private Limited
IndiaHyderabadManufacturingBiotechnologyEnergyRenewable EnergyManufacturingBiotechnologyDescription
Piramal Pharma Ltd. has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited, bringing its total ownership to 74%. This acquisition enhances Piramal's capabilities in the biologics sector and positions Yapan Bio as a subsidiary. The strategic move aims to expand the company’s service offerings and accelerate the development of complex biologic therapies.
Don't miss Piramal Pharma Limited's next move
Get an email the moment Piramal Pharma Limited makes an acquisition, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Yapan Bio Private Limited?
Yapan Bio Private Limited was acquired by Piramal Pharma Limited, based in India. The deal was reported on August 18, 2026. Piramal Pharma Limited is a significant player in the pharmaceutical industry, focused on manufacturing active pharmaceutical ingredients and intermediates. Piramal Pharma Limited is privately held and operates in Manufacturing.
When did Piramal Pharma Limited acquire Yapan Bio Private Limited?
Piramal Pharma Limited's acquisition of Yapan Bio Private Limited was reported on August 18, 2026. Piramal Pharma Ltd. has completed the acquisition of an incremental 40.67% stake in Yapan Bio Private Limited, bringing its total ownership to 74%. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Yapan Bio Private Limited do?
Yapan Bio Private Limited is a Contract Development and Manufacturing Organization (CDMO) specializing in vaccines and biologics. The company is focused on providing large molecule capabilities and plays a key role in advancing biologic therapies. It is privately held, operating in Manufacturing, and is based in Hyderabad.